Wednesday, February 3, 2010

Raindance appoints Banerjee CEO

By Mass High Tech staff

Video Gallery

MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges

MHT's Galen Moore: Honoring innovation in New England

MHT's Galen Moore: Hiring trends and opportunities

Related News

Pescatello named president of New England Biotech Association [March 15, 2010]

Boston Scientific stock drops on heart device recall [March 15, 2010]

Raytheon's Sanchez joins Mass. STEM Advisory Council [March 15, 2010]

Fluidnet rounds out $17M backing for IV fluid pumps [March 12, 2010]

CEO Ken Bero brings team concept Datawatch [March 12, 2010]

Lexington-based drug discovery toolmaker Raindance Technologies Inc. has named Sirshendu Roopom Banerjee its new president and CEO. Banerjee replaces Christopher McNary, who has held the position since November 2007, and will take the role of chief commercial officer.

Banerjee joins Raindance having most recently served as director of health-care investment banking at Leerink Swann, leading Life Science Tools and Diagnostics. Prior to Leerink Swann, he worked for Goldman Sachs, advising Fortune 500 health-care firms about global expansion, mergers and acquisitions, growth strategy and product development and launch strategy. He has also previously worked for the Dana Farber Cancer Institute, the Whitehead Institute/MIT Human Genome Project and Mass General Hospital Cancer Center. Banerjee graduated with an M.P.P. from Harvard University’s Kennedy School of Government and two bachelor of science degrees in biology and economics from MIT.

Raindance Technologies makes and sells microdroplet-based devices and related tools to accelerate human health and disease research.

The privately held company raised $6 million last May, of a proposed $12 million round. The company was a recipient in December 2008 of a three-year Massachusetts Life Sciences Center grant, valued at 250,000 per year, to develop an individual cell data collector via a fluorescence-activated cell sorter.